Dose-escalating Trial With UniCAR02-T Cells and PSMA Target Module (TMpPSMA) in Patients With Progressive Disease After Standard Systemic Therapy in Cancers With Positive PSMA Marker
Clinical trial NCT04633148 · TERMINATED
Trial details
- NCT number
- NCT04633148
- Sponsor
- AvenCell Europe GmbH
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-23
- Primary completion
- 2024-03-28
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.